Dow Inc. (NYSE:DOW) is reportedly considering selling its 35% stake in Sadara Chemical, its $20 billion chemicals joint venture with Saudi Aramco, as the company continues to reshape its portfolio amid a prolonged downturn in the global chemicals industry. No final decision has been made, and Aramco or another strategic or financial investor could potentially acquire Dow's stake.
The potential exit comes as Sadara has become a significant financial burden for Dow. As of June 30, Dow Inc. (NYSE:DOW) had a negative investment balance of $793 million in Sadara and had suspended recognition of its share of the venture's equity losses in the first quarter. Dow has also been exposed to Sadara's financing obligations and previously disclosed that the venture had drawn on a credit facility.
At the same time, Sadara remains a major industrial ****** et, operating a complex in Jubail with more than 3 million metric tons of annual chemicals and plastics capacity. Its operations were disrupted earlier this year by the Middle East conflict, adding transportation, supply-chain, and operating pressures to an industry already dealing with weak demand and global oversupply.
The strongest argument for Dow Inc. (NYSE:DOW) is that exiting Sadara could remove a persistent drag on cash flow and allow management to redirect capital toward businesses with better returns. Dow's exposure to Sadara is no longer simply an investment in a large Saudi chemicals complex; the company has accumulated a negative investment balance and financial obligations ****** ociated with the venture. A sale could therefore reduce Dow's exposure to future funding requirements and limit the amount of capital that could otherwise have to be committed to the partnership.
That would be particularly valuable because Dow is already trying to improve its cash generation. Management has said its objective is to reach free-cash-flow breakeven while pursuing significant cost reductions. In March, CEO Jim Fitterling said Dow's goal was to avoid putting additional cash into Sadara during 2026, while describing the venture as having low operating cash costs but more challenging fixed costs and financing obligations.
#chemicals
The potential exit comes as Sadara has become a significant financial burden for Dow. As of June 30, Dow Inc. (NYSE:DOW) had a negative investment balance of $793 million in Sadara and had suspended recognition of its share of the venture's equity losses in the first quarter. Dow has also been exposed to Sadara's financing obligations and previously disclosed that the venture had drawn on a credit facility.
At the same time, Sadara remains a major industrial ****** et, operating a complex in Jubail with more than 3 million metric tons of annual chemicals and plastics capacity. Its operations were disrupted earlier this year by the Middle East conflict, adding transportation, supply-chain, and operating pressures to an industry already dealing with weak demand and global oversupply.
The strongest argument for Dow Inc. (NYSE:DOW) is that exiting Sadara could remove a persistent drag on cash flow and allow management to redirect capital toward businesses with better returns. Dow's exposure to Sadara is no longer simply an investment in a large Saudi chemicals complex; the company has accumulated a negative investment balance and financial obligations ****** ociated with the venture. A sale could therefore reduce Dow's exposure to future funding requirements and limit the amount of capital that could otherwise have to be committed to the partnership.
That would be particularly valuable because Dow is already trying to improve its cash generation. Management has said its objective is to reach free-cash-flow breakeven while pursuing significant cost reductions. In March, CEO Jim Fitterling said Dow's goal was to avoid putting additional cash into Sadara during 2026, while describing the venture as having low operating cash costs but more challenging fixed costs and financing obligations.
#chemicals
4 hours ago
